Literature DB >> 27536659

East Meets West: Harmony but Not Uniformity.

Zhi-Hong Liu1.   

Abstract

Year:  2015        PMID： 27536659      PMCID： PMC4934799          DOI： 10.1159/000382139

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN： 2296-9357


× No keyword cloud information.
  9 in total

1.  'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

Authors:  Allan J Collins; Robert N Foley; Blanche Chavers; David Gilbertson; Charles Herzog; Kirsten Johansen; Bertram Kasiske; Nancy Kutner; Jiannong Liu; Wendy St Peter; Haifeng Guo; Sally Gustafson; Brooke Heubner; Kenneth Lamb; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Bryn Thompson; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frank Daniels; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2012-01       Impact factor: 8.860

2.  UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses.

Authors:  Julie Gilg; Clare Castledine; Damian Fogarty; Terry Feest
Journal:  Nephron Clin Pract       Date:  2011-08-26

Review 3.  International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.

Authors:  Ravindra L Mehta; Jorge Cerdá; Emmanuel A Burdmann; Marcello Tonelli; Guillermo García-García; Vivekanand Jha; Paweena Susantitaphong; Michael Rocco; Raymond Vanholder; Mehmet Sukru Sever; Dinna Cruz; Bertrand Jaber; Norbert H Lameire; Raúl Lombardi; Andrew Lewington; John Feehally; Fredric Finkelstein; Nathan Levin; Neesh Pannu; Bernadette Thomas; Eliah Aronoff-Spencer; Giuseppe Remuzzi
Journal:  Lancet       Date:  2015-03-13       Impact factor: 79.321

4.  Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.

Authors:  Sydney Tang; Joseph C K Leung; Loretta Y Y Chan; Yun Hoi Lui; Colin S O Tang; Chi Hang Kan; Yiu Wing Ho; Kar Neng Lai
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

5.  Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.

Authors:  Gershon Frisch; Julie Lin; Jordan Rosenstock; Glen Markowitz; Vivette D'Agati; Jai Radhakrishnan; Dean Preddie; John Crew; Anthony Valeri; Gerald Appel
Journal:  Nephrol Dial Transplant       Date:  2005-07-19       Impact factor: 5.992

6.  Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

Authors:  Bart D Maes; Raymond Oyen; Kathleen Claes; Pieter Evenepoel; Dirk Kuypers; Johan Vanwalleghem; Boudewijn Van Damme; Yves F Ch Vanrenterghem
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

Review 7.  Nephrology in china.

Authors:  Zhi-Hong Liu
Journal:  Nat Rev Nephrol       Date:  2013-07-23       Impact factor: 28.314

8.  Long-term study of mycophenolate mofetil treatment in IgA nephropathy.

Authors:  Sydney C W Tang; Anthony W C Tang; Sunny S H Wong; Joseph C K Leung; Yiu Wing Ho; Kar Neng Lai
Journal:  Kidney Int       Date:  2009-12-23       Impact factor: 10.612

9.  New Insights into the Pathogenesis of IgA Nephropathy.

Authors:  Jan Novak; Dana Rizk; Kazuo Takahashi; XianWen Zhang; Qi Bian; Hirouki Ueda; Yoshimi Ueda; Colin Reily; Ling-Yun Lai; Chuanming Hao; Lea Novak; Zhi-Qiang Huang; Matthew B Renfrow; Hitoshi Suzuki; Bruce A Julian
Journal:  Kidney Dis (Basel)       Date:  2015-05-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.